What is Amphastar Pharmaceuticals's net change in cash?

Amphastar Pharmaceuticals (AMPH) reported net change in cash of $762K in Q1 2026.

How has Amphastar Pharmaceuticals's net change in cash changed year-over-year?

Amphastar Pharmaceuticals's net change in cash decreased by 97.6% year-over-year, from $31.17M to $762K.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Amphastar Pharmaceuticals AMPH Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Halozyme TherapeuticsHALO

$175.59M+190%

ViatrisVTRS

$457.7M+2,166%

Opko HealthOPK

-$27.18M-769%

AptarGroupATR

-$179.9M-83.6%

ARS Pharmaceuticals, Inc.SPRY

-$17M-55.2%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's net change in cash?: Amphastar Pharmaceuticals (AMPH) reported net change in cash of $762K in Q1 2026.
How has Amphastar Pharmaceuticals's net change in cash changed year-over-year?: Amphastar Pharmaceuticals's net change in cash decreased by 97.6% year-over-year, from $31.17M to $762K.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.